There are 2867 resources available
494TiP - Phase Ib study of elimusertib (ATRi; BAY 1895344) in combination with niraparib (PARPi) in patients with advanced solid tumors
Presenter: Timothy Yap
Session: Poster session 13
495TiP - A phase II study evaluating the safety and efficacy of ENV-101 (taladegib) in patients with advanced solid tumors harboring PTCH1 loss of function mutations
Presenter: Jason Luke
Session: Poster session 13
500P - The impact of COVID-19 on the management and outcome of oncology patients: The results of the Middle East and North African (MENA) COVID-19 and Cancer Registry (MCCR)
Presenter: Abdul Rahman Jazieh
Session: Poster session 13
501P - A prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19
Presenter: Susan Halabi
Session: Poster session 13
502P - Association of immunotherapy and immunosuppression with severe COVID-19 disease in patients with cancer
Presenter: Ziad Bakouny
Session: Poster session 13
503P - The IMPRESS-Norway trial: Improving public cancer care by implementing precision cancer medicine in Norway
Presenter: Aaslaug Helland
Session: Poster session 13
504P - SARS-CoV-2 Omicron (B.1.1.529) variant infection leads to high morbidity and mortality in unvaccinated patients with cancer
Presenter: David Pinato
Session: Poster session 13
505P - The impact of COVID-19 on the wellness and resilience of the Canadian medical oncology workforce: A Canadian Association of Medical Oncologists survey
Presenter: Lauren Jones
Session: Poster session 13
506P - The prognostic utility of neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) in carcinoma of unknown primary (CUP): An experience from a tertiary UK cancer centre
Presenter: Julie- Anne Scott
Session: Poster session 13
507P - Clinical characteristics and survival outcomes in neuroblastoma: A single center study at a regional cancer center
Presenter: Anudeep Padakanti
Session: Poster session 13